We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+2.19%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.37B
AUM Growth
-$79.1M
Cap. Flow
-$328M
Cap. Flow %
-23.94%
Top 10 Hldgs %
16.21%
Holding
364
New
83
Increased
69
Reduced
93
Closed
66

Top Buys

Rank Stock Value
1
WYNN icon
Wynn Resorts
WYNN
+$22.1M
2
LVS icon
Las Vegas Sands
LVS
+$21.2M
3
TAP icon
Molson Coors Class B
TAP
+$7.08M
4
OA
Orbital ATK, Inc.
OA
+$6.56M
5
GGG icon
Graco
GGG
+$6.07M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$10.5M
2
HHH icon
Howard Hughes
HHH
+$9.77M
3
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$9.72M
4
JACK icon
Jack in the Box
JACK
+$9.49M
5
EXPE icon
Expedia Group
EXPE
+$8.47M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18%
2 Technology 12.96%
3 Industrials 9.99%
4 Financials 7.69%
5 Healthcare 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HEES
201
DELISTED
H&E Equipment Services
HEES
$1.85M 0.14%
+105,819
New +$1.53M
IQV icon
202
IQVIA
IQV
$38.3B
$1.84M 0.13%
+28,259
New +$1.79M
BYD icon
203
Boyd Gaming
BYD
$6.11B
$1.83M 0.13%
+88,591
New +$1.57M
DOC
204
DELISTED
PHYSICIANS REALTY TRUST
DOC
$1.82M 0.13%
97,920
-56,354
-37% -$971K
AGN
205
DELISTED
Allergan plc
AGN
$1.82M 0.13%
6,781
-5,174
-43% -$1.48M
MDVN
206
DELISTED
MEDIVATION, INC.
MDVN
$1.82M 0.13%
+39,496
New +$1.43M
EVHC
207
DELISTED
Envision Healthcare Holdings Inc
EVHC
$1.81M 0.13%
+29,563
New +$1.94M
DSGX icon
208
Descartes Systems
DSGX
$6.67B
$1.79M 0.13%
91,539
-10,704
-10% -$188K
RAMP icon
209
LiveRamp
RAMP
$2.3B
$1.78M 0.13%
+83,046
New +$1.65M
DERM
210
DELISTED
Dermira, Inc.
DERM
$1.76M 0.13%
85,343
+14,373
+20% +$353K
MDCO
211
DELISTED
Medicines Co
MDCO
$1.73M 0.13%
54,483
-27,937
-34% -$912K
PEN icon
212
Penumbra
PEN
$12.8B
$1.72M 0.13%
+37,423
New +$1.75M
NSTG
213
DELISTED
NanoString Technologies, Inc.
NSTG
$1.69M 0.12%
111,274
-47,935
-30% -$677K
RARE icon
214
Ultragenyx Pharmaceutical
RARE
$2.55B
$1.59M 0.12%
25,142
-4,017
-14% -$263K
TXMD icon
215
TherapeuticsMD
TXMD
$24.2M
$1.58M 0.12%
4,938
-691
-12% -$236K
LOXO
216
DELISTED
Loxo Oncology, Inc
LOXO
$1.55M 0.11%
56,645
+92
+0.2% +$1.93K
LNKD
217
DELISTED
LinkedIn Corporation
LNKD
$1.54M 0.11%
+13,468
New +$1.98M
SAVE
218
DELISTED
Spirit Airlines, Inc.
SAVE
$1.38M 0.1%
+28,754
New +$1.29M
JAZZ icon
219
Jazz Pharmaceuticals
JAZZ
$16.7B
$1.36M 0.1%
10,395
-3,173
-23% -$395K
KITE
220
DELISTED
Kite Pharma, Inc.
KITE
$1.34M 0.1%
+29,181
New +$1.41M
ANAC
221
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$1.34M 0.1%
25,066
-41,215
-62% -$3.04M
HUM icon
222
Humana
HUM
$44.1B
$1.28M 0.09%
6,983
+2,170
+45% +$376K
CRUS icon
223
Cirrus Logic
CRUS
$6.19B
$1.25M 0.09%
+34,244
New +$1.11M
STRR
224
DELISTED
Star Equity Holdings
STRR
$1.24M 0.09%
5,000
– –
BMY icon
225
Bristol-Myers Squibb
BMY
$131B
$1.24M 0.09%
+19,384
New +$1.22M
7 8
9
10 11

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q1 2016 Portfolio in Review

As of Q1 2016, Nicholas Investment Partners held 364 positions worth $1.37B, down 5.5% from $1.45B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Nicholas Investment Partners withdrew a net $328M in Q1 2016, closing 66 positions and reducing 93 holdings. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $10.5M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

Against the trend, Nicholas Investment Partners opened a new position in Wynn Resorts worth $28M.

  • Nicholas Investment Partners's largest Q1 2016 buy was Wynn Resorts: 300,000 shares worth $28M.
  • Nicholas Investment Partners added most to Las Vegas Sands in Q1 2016, an estimated $21.2M increase.
  • Nicholas Investment Partners's biggest Q1 2016 reduction was Vail Resorts, cutting an estimated $6.84M.
  • Nicholas Investment Partners fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2016, selling an estimated $10.5M.
  • Nicholas Investment Partners's ten largest holdings make up 16% of its $1.37B portfolio in Q1 2016.
  • Nicholas Investment Partners opened 83 new positions and closed 66 in Q1 2016.
  • Nicholas Investment Partners's portfolio value fell 5.5% quarter-over-quarter to $1.37B.

Based on Nicholas Investment Partners's 13F filing for Q1 2016, filed 13 May 2016.